Orbital fibroblast interleukin-6 gene expression and immunomodulation

Ophthalmic Plastic and Reconstructive Surgery

Volumn 15, Issue 5, 1999, Pages 306-311

  Burnstine, M A ^a   Elner, S G ^a   Strieter, R M ^a   Kunkel, S L ^a   Elner, V M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; INTERLEUKIN 6;

ARTICLE; CELL INFILTRATION; CORTICOSTEROID THERAPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOMODULATION; ORBIT DISEASE; ORBIT INFECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0033284140     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002341-199909000-00002     Document Type: Article

References (44)

1. Differential expression of immunoreactive HLA-DR and ICAM-1 in human cultured orbital fibroblasts and orbital tissue
2. Interleukin-8 and monocyte chemotactic protein-1 gene expression and protein production by human orbital fibroblasts
3. Properties of the novel proinflammatory supergene 'intercrine' cytokine family
4. The immunopathology of chemotactic cytokines: The role of interleukin-8 and monocyte chemoattractant protein-1
5. Interleukin-8 and related chemotactic cytokines - CXC and CC chemokines
6. Interleukin-6: An overview
7. Isolation of biologically active RNA from sources enriched in ribonuclease
8. Epidermal keratin gene expressed in embryos of Xenopus laevis
9. Inhibitory effect of dexamethasone and progesterone in vitro on proliferation of human renal cell carcinomas and effects on expression of interleukin-6 or interleukin-6 receptor
10. The nonspecific orbital inflammatory syndromes
11. Orbital lymphoproliferative and inflammatory lesions
12. Thyroid-associated eye disease: Pathophysiology
13. Orbital fibroblast chemokine modulation: Effects of dexamethasone and cyclosporin-A
14. Multiple actions of interleukin-6 within a cytokine network
15. B-cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T-lymphocytes
16. The biology of interleukin-6
17. Biology of multifunctional cytokines: IL-6 and related molecules (IL-1 and TNF)
18. Interleukin-6: A multifunctional cytokine regulating immune reactions and the acute phase protein response
19. Endotoxemia elicits increased circulating IL-6 in man
20. IL-1 and tumor necrosis factor synergistically stimulate fibroblast IL-6 production and stabilize IL-6 messenger RNA
21. Regulation of interleukin-6 expression in cultured human blood monocytes and monocyte-derived macrophages
22. Inducible production of interleukin-6 by human polymorphonuclear neutrophils: Role of granulocyte-macrophage colony-stimulating factor and tumor necrosis factor-alpha
23. Interleukin-6 (IL-6) gene expression and secretion by cytokine-stimulated human retinal pigment epithelial cells
24. IL-1 stimulates IL-6 production in endothelial cells
25. Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats
26. Cytokines and their receptors: Molecular mechanisms of interleukin-6 gene repression by glucocorticoids
27. Retinal pigment epithelial cells secrete interleukin-6 in response to interleukin-1
28. Dexamethasone and Cyclosporin A modulation of human retinal pigment epithelial cell monocyte chemotactic factor protein -1 and interleukin-8
29. Aqueous humor interleukin-6 levels in uveitis
30. Analysis of IL-6 levels in human vitreous fluid obtained from uveitis patients, patients with proliferative intraocular disorders and eye bank eyes
31. Role of interleukin 6 in the inflammatory response after cataract surgery. An experimental and clinical study
32. Kinetics of intraocular tumor necrosis factor and interleukin-6 in endotoxin-induced uveitis in the rat
33. Analysis of interleukin-6 in endotoxin-induced uveitis
34. Uses, adverse effects of abuse of corticosteroids. Part I
35. Inhibition by glucocorticoids of the formation of interleukin-1b, and interleukin-6: Mediation by decreased mRNA stability
36. Cytokine-stimulated human dermal microvascular endothelial cells produce interleukin-6 inhibition by hydrocortisone, dexamethasone, and calcitrol
37. On mechanism for efficient repression of the interleukin-6 promotor by glucocorticoids: Enhancer, TATA box, and RNA start site occlusion
38. Dexamethasone inhibits production of interleukin-6 by cultured cardiac myxoma cells
39. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells, and fibroblasts
40. Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: Evidence for transcriptional and post-transcriptional regulatory mechanisms
41. The mechanism of action of FK-506 and cyclosporin-A
42. Effects of FK 506 and cyclosporine on the expression of IL-6 and its receptor on stimulated monocytes
43. Cyclosporin A does not inhibit IL-1-a induced epithelial cell IL-6 secretion